DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Preliminary Results/Development of Sales SHOP APOTHEKE EUROPE continues dynamic growth course in 2016. 24.01.2017 / 06:58 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN. - SHOP APOTHEKE EUROPE continues dynamic growth course in 2016. * Revenues increased by 41 % to EUR 177 million. * Significant growth in all segments. * Substantial investment programme launched. Venlo, January 24, 2017. SHOP APOTHEKE EUROPE N.V., Venlo, Europe's leading online OTC pharmacy (OTC = over the counter = non-prescription medications), has posted revenues of EUR 177 million for the 2016 fiscal year according to preliminary unaudited results. That's a year-to-year revenue increase of 41 % compared to the EUR 126 million posted in 2015. The rise in operational growth is the result of a substantial increase in the number of active customers from 1.3 million at the end of 2015 to 1.8 million at the end of 2016 along significant revenue growth in all segments. Revenues in Germany, currently the company's biggest segment, rose 25 % year-to-year to EUR 145 million, from EUR 116 million the previous year. In the international regions - which include Austria, France, Belgium, the Netherlands, Spain and Italy - SHOP APOTHEKE EUROPE has more than tripled its transaction volume, leading to a year-to-year revenue increase to EUR 30 million (compared to EUR 8 million in 2015). The third segment, "Germany Services," which provides web shop services, had a 2016 gross turnover of EUR 4 million prior to the elimination of intragroup transactions compared to the EUR 3 million posted during fiscal year 2015. SHOP APOTHEKE EUROPE CFO Dr. Ulrich Wandel provides an initial assessment: "2016 was a successful year for us. We saw a strong fourth quarter during which our revenues grew c. 50 % year-to-year to c. EUR 52 million. That means we were able to meet our ambitious 2016 growth targets; extended our market leadership in relevant European countries; and further accelerated our strong growth rates in our new markets. This positive momentum continues during the first weeks of the new fiscal year 2017." To support the company's international growth, SHOP APOTHEKE EUROPE has launched an extensive investment programme, starting with the construction of a high-bay warehouse system at the central logistics site in Venlo, the Netherlands. Over the next three years the company will invest a total of EUR 30 million in expanding and upgrading operations and IT at the Venlo site. As of December 31, 2016, SHOP APOTHEKE EUROPE employed 324 staff, a substantial increase from 251 employees a year earlier. SHOP APOTHEKE EUROPE will publish detailed financial results for the 2016 fiscal year on March 27, 2017, when the company's consolidated financial statements will be released. FINANCIAL CALENDAR 2017 March 27, 2017 Publication of the Full-Year Results 2016 May 15, 2017 Publication of the First Quarter Results 2017 May 16, 2017 Annual General Meeting July 26, 2017 Publication of the Half-Year Report 2017 November 9, 2017 Publication of the Third Quarter Results 2017 CONFERENCES 2017 May 17-18, 2017 Citi's European Internet and Digital Conference, London May 22-24, 2017 Berenberg European Conference USA 2017, Tarrytown, NY August 29-31, 2017 Commerzbank Conference, Frankfurt September 6-8, 2017 Citi Global Technology Conference, New York September 18-20, 2017 Berenberg & Goldman Sachs German Corporate Conference, Munich ABOUT SHOP APOTHEKE EUROPE SHOP APOTHEKE EUROPE is Continental Europe's leading online OTC pharmacy with a portfolio that focuses on OTC medication and pharmacy-related BPC products. The Company operates online pharmacies in Germany, Austria, France, Belgium, Italy, Spain and the Netherlands. In Germany, TÜV-certified shop-apotheke.com is the market leader in terms of traffic. SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to 1.8 million active customers quickly and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive and consistent pharmaceutical services. SHOP APOTHEKE EUROPE generated EUR 177 million in revenues in the financial year 2016. Headquartered in Venlo (Netherlands), SHOP APOTHEKE EUROPE also has an administration site for its sales and marketing units in Cologne (Germany) and an international service center in Tongeren, Belgium. The online pharmacy has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016. MEDIA CONTACTS Trade and public media: Sven Schirmer Mobile: +49 152 28 50 63 61 E-Mail: [email protected] Financial media: Thomas Schnorrenberg Mobile: +49 151 46 53 13 17 E-Mail: [email protected] Investor Relations: Dr. Ulrich Wandel Phone: +31 77 850 6117 E-Mail: [email protected] DISCLAIMER This announcement does not constitute a public offer or an offer to subscribe to any securities in any jurisdiction. The offer was made exclusively on the basis of the company's securities prospectus that had been published in connection with the offer. The shares have already been sold. This announcement contains forward-looking statements that relate to the future course of business and future financial performance, as well as future transactions or developments concerning SHOP APOTHEKE EUROPE. The bases of these statements are current expectations and assumptions of SHOP APOTHEKE EUROPE's management, of which a large number are outside SHOPE APOTHEKE EUROPE's sphere of influence. These statements are therefore subject to a variety of risks and uncertainties. If such risks and uncertainties occur, or if the underlying expectations do not materialize or the assumptions made are not correct, the actual events, both positive and negative, may differ materially from those events contained in the forward-looking statements. SHOP APOTHEKE EUROPE assumes no obligation to update these forward-looking statements or to correct them in the event of occurrences or developments other than those anticipated. Such updates or corrections are not intended. --------------------------------------------------------------------------- 24.01.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: SHOP APOTHEKE EUROPE N.V. Dirk Hartogweg 14 5928 LV Venlo Netherlands Phone: 0800 - 200 800 300 Fax: 0800 - 90 70 90 20 E-mail: [email protected] Internet: www.shop-apotheke-europe.com ISIN: NL0012044747 WKN: A2AR94 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange End of News DGAP News Service --------------------------------------------------------------------------- 538547 24.01.2017